Search

everythinglearnresearchcommunity

for

Search:↓

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 can cause temporary hair loss.

The pandemic stress may have increased alopecia cases in Bangladesh.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Long-COVID symptoms can last more than a year and change over time.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

No single biomarker is reliable enough for diagnosing and assessing SLE.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

A functional medicine approach may help long COVID patients by focusing on adrenal fatigue, gut health, and vitamin D deficiency, using diagnostic tools and lifestyle changes.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Some people lose a lot of hair after having COVID-19.